重大事件
即時報告
8-K
2026-06-11
Parabilis Medicines 提交8-K 通報重大協議、股權銷售及章程修訂
AI 繁中摘要
Parabilis Medicines, Inc.（納斯達克代碼：未提供）於2026年6月11日提交8-K表格，通報多項重大企業行動。根據文件，公司已簽訂一項重大最終協議（Item 1.01），同時進行未經註冊的股權證券銷售（Item 3.02），並修訂公司章程或細則，及變更財政年度（Item 5.03）。相關協議及章程修訂細節已作為附件（EX-3.1、EX-3.2、EX-10.1）提交，惟8-K正文未披露具體交易對手、條款及所涉金額。該公司為專注藥物製劑的生物製藥企業，總部位於麻省劍橋。是次申報未提供管理層評論或業績數字，投資者需查閱附件了解對股權結構及公司治理的潛在影響。
展開英文正文
EDGAR Filing Documents for 0001193125-26-267550 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-267550 Filing Date 2026-06-11 Accepted 2026-06-11 16:12:52 Documents 12 Period of Report 2026-06-09 Items Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K ck0001657677-20260609.htm iXBRL 8-K 77118 2 EX-3.1 ck0001657677-ex3_1.htm EX-3.1 76514 3 EX-3.2 ck0001657677-ex3_2.htm EX-3.2 216855 4 EX-10.1 ck0001657677-ex10_1.htm EX-10.1 86221 Complete submission text file 0001193125-26-267550.txt 639186 Data Files Seq Description Document Type Size 5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001657677-20260609.xsd EX-101.SCH 28040 15 EXTRACTED XBRL INSTANCE DOCUMENT ck0001657677-20260609_htm.xml XML 5098 Mailing Address 30 ACORN PARK DRIVE 6TH FLOOR CAMBRIDGE MA 02140 Business Address 30 ACORN PARK DRIVE 6TH FLOOR CAMBRIDGE MA 02140 617-945-9510 Parabilis Medicines, Inc. (Filer) CIK: 0001657677 (see all company filings) EIN.: 474505725 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-43331 | Film No.: 261083157 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)